Izindaba
Imiphumela Ethembisayo Yokwelashwa Kwe-CD7 CAR-T Ehlanganiswe Nokufakelwa Kwesibili Ezigulini Eziphinde Zabuyela Kamuva T-ALL/LBL
Ucwaningo lwakamuva lugqamisa ukusebenza kahle kokwelashwa kwe-CD7 CAR-T okulandelwa i-allogeneic hematopoietic stem cell transplantation (HSCT) yesibili ezigulini ezine-T-cell acute lymphoblastic leukemia (T-ALL) ne-lymphoblastic lymphoma (LBL) ephinde yabuyela emuva (T-ALL) kanye ne-lymphoblastic lymphoma (LBL), ekhombisa amandla amakhulu ukuzuza i-minimal residual disease (MRD) -negative ukuxolelwa okuphelele.
Ukusebenza Kwesikhathi Eside Kwe-CD19 CAR T-Cell Therapy ekwelapheni I-Relapsed/Refractory Acute Lymphoblastic Leukemia
Ucwaningo olubalulekile lubonisa impumelelo yesikhathi eside yokwelashwa kwe-CD19 CAR T-cell ekwelapheni iziguli ezine-acute lymphoblastic leukemia (ALL) ebuyele emuva/esabelayo elandela ukufakelwa kwe-allogeneic hematopoietic stem cell, okunikeza ithemba elisha ku-hematology.
I-Bioocus Ithuthukisa I-Frontier Ekwelapheni I-Pediatric Acute Lymphoblastic Leukemia
I-Bioocus ihamba phambili ekuthuthukiseni izindlela zokwelapha ze-CAR-T zesizukulwane esilandelayo. Ukushicilelwa kwakamuva kukaDkt. Chunrong Tong nethimba lakhe esibhedlela i-Lu Daopei kugqamisa intuthuko nezinselele ezibucayi ekusetshenzisweni kokwelashwa kwe-CD19 CAR-T yesizukulwane sesibili ezigulini zezingane, okubonisa ukuzibophezela kukaBiocus ekwelapheni umdlavuza okusha.
Ukuphayona I-CAR-T Therapy ku-B-cell Acute Lymphoblastic Leukemia Ibonisa Ukusebenza Okungakaze Kubonwe
Ucwaningo oluyisisekelo lugqamisa ukusebenza okumangalisayo kokwelashwa kwamaseli e-CAR-T ekwelapheni i-B-cell Acute Lymphoblastic Leukemia (B-ALL). Ucwaningo, olubandakanya ukusebenzisana ne-BIOOCUS kanye neSibhedlela saseLu Daopei, lubonisa intuthuko enkulu, lusungula ukwelashwa njengendlela yokwelapha ebalulekile.
Imithi Emisha Yokwelapha Yeseli ye-CAR-T Iguqula Ukwelashwa Kwezifo Ezilimazayo Zamaseli
Abacwaningi baseSibhedlela i-Lu Daopei nabahlanganyeli bamazwe ngamazwe bahlola izindlela zokwelapha zamaseli e-CAR-T ezisezingeni eliphezulu, ezinikeza ithemba ezigulini ezinomdlavuza we-B cell. Lolu cwaningo lugqamisa intuthuko ekwakhiweni nasekusetshenzisweni, lubonisa imiphumela ethembisayo namandla ezinto ezintsha ezizayo.
Ukusebenza Okuthuthukisiwe Kwe-Antitumor Kwamaseli e-CD19 CAR-T Asekelwe ku-4-1BB ekwelapheni i-B-ALL
Ucwaningo lwakamuva lwemitholampilo lwembula ukuthi amaseli e-CD19 CAR-T asuselwa ku-4-1BB akhombisa ukusebenza kahle kwe-antitumor uma kuqhathaniswa namaseli e-CAR-T asekelwe ku-CD28 ekwelapheni i-B cell acute lymphoblastic leukemia (r/r B-ALL) ebuyele emuva noma ephikisayo.
I-Lu Daopei Hospital's Low-Dose CD19 CAR-T Therapy Ibonisa Imiphumela Ethembisayo Ezigulini Ze-B-ALL
Ucwaningo lwakamuva eSibhedlela i-Lu Daopei lubonise ukusebenza kahle nokuphepha okuphezulu komthamo ophansi we-CD19 CAR-T cell therapy ekwelapheni iziguli ze-B acute lymphoblastic leukemia (B-ALL) eziphikayo noma eziphinde zabuyela emuva. Ucwaningo, oluhlanganisa iziguli ze-51, lubonise izinga lokukhululwa okuphelele elimangalisayo elinemiphumela emibi emincane.
Isu Lomgqugquzeli Unoveli Lithuthukisa Ukuphepha kanye Ukusebenza Ngempumelelo Kwe-CAR-T Therapy ku-Acute B Cell Leukemia
Isibhedlela i-Lu Daopei kanye ne-Hebei Senlang Biotechnology bamemezele imiphumela ethembisayo evela ocwaningweni lwabo lwakamuva mayelana nokuphepha nokusebenza ngempumelelo kokwelashwa kwe-CAR-T kwe-acute B cell leukemia. Lokhu kubambisana kugqamisa amandla emiklamo yeseli ye-CAR-T yokuthuthukisa imiphumela yesiguli.
Ucwaningo Oluyimpumelelo Lubonisa Ukuphepha kanye Ukusebenza Kokwelapha Kwe-CAR-T Ekwelapheni I-B-Cell Malignancies
Ucwaningo olusha oluholwa nguDkt. Zhi-tao Ying wasePeking University Cancer Hospital lubonise ukuphepha nokusebenza ngempumelelo kwe-IM19 CAR-T cell therapy ekwelapheni izifo ze-B-cell hematologic ezibuyele emuva futhi eziphikisayo. Ishicilelwe kuIjenali yaseShayina Yezidakamizwa Ezintsha, ucwaningo lubika ukuthi iziguli ezingu-11 kwezingu-12 zithole ukuxolelwa okuphelele ngaphandle kwemiphumela emibi kakhulu, okubonisa amandla e-IM19 njengendlela yokwelapha ethembisayo yeziguli ezinezinye izindlela ezilinganiselwe.
Intuthuko Ethuthukile Kumaseli Okubulala Wemvelo (NK) Ngaphezu kweminyaka engama-50
Emashumini amahlanu eminyaka adlule, ucwaningo lwamangqamuzana Okubulala Kwemvelo (NK) lwenze ushintsho ekuqondeni kwethu ukungatheleleki okungokwemvelo, okunikeza izindlela ezintsha ezithembisayo zomdlavuza kanye nokwelapha ngegciwane.
Ukuqeqeshwa Konyaka Kokulawulwa Kwegazi Lomtholampilo Nokudluliselwa Kwegazi Okubanjelwe esibhedlela sase-Yanda Ludaopei
Uqeqesho Lwaminyaka Yonke lwango-2024 lweClinical Blood Management and Transfusion Technology eSanhe City lubanjwe ngempumelelo esibhedlela saseYanda Ludaopei. Lo mcimbi uhlose ukuthuthukisa ukuphathwa kwegazi emitholampilo kanye nokuphepha kokumpontshelwa ngokusebenzisa izikhathi zokuqeqesha ezibanzi ezihanjelwa ochwepheshe bezempilo abangaphezu kwe-100 abavela ezikhungweni zezokwelapha ezihlukahlukene.
Ukuphumelela Kwezifo Ezizenzakalelayo Zezingane: I-CAR-T Cell Therapy Yelapha Isiguli Se-Lupus
Ucwaningo oluphambili eSibhedlela sase-Erlangen University lwelaphe ngempumelelo intombazane eneminyaka engu-16 ubudala ene-systemic lupus erythematosus (SLE) enzima kusetshenziswa ukwelashwa kweseli ye-CAR-T. Lokhu kuphawula ukusetshenziswa kokuqala kwalokhu kwelashwa kwe-lupus yezingane, okunikeza ithemba elisha ezinganeni ezinezifo ezizimele.